Japan study tour
Release time:
2020-07-22
focuses on improvement, standards, and refinement. altruism
this tour experience
recently visited Japan with the research group and went to Toyota TPS lean practice dojo for training and study. around the theme of lean management, Toyota company and its suppliers and manufacturers in Nagoya, Shizuoka, Tokyo and other places were visited on the spot.
was the reward itinerary arranged by the head goose class. I didn't expect much at the beginning, but with the change of mentality from passive to devotion, my group members and I constantly felt that Japan's development had entered a stage of highly developed civilization. Whether it is economic, political, cultural, or national quality, we have a big gap with them. We must always reflect on ourselves, police and encourage ourselves, learn from Japan's strengths, and solve internal and external problems through continuous learning and improvement, so as to seize the opportunity to achieve better development.
Here, I will share what I have seen, heard, learned and thought during my stay in Japan from the aspects of Japan's economy, culture and lean management of enterprises.
1. face up to the gap between the economic development of the two countries
In 1991 , Japan entered a long-term economic downturn after the bubble economy burst. Many enterprises were deeply trapped in the economic quagmire, including the AVEX company we visited. In these 20 years, China has prospered and developed. Our Chinese people's clothing, food, housing and transportation have been continuously upgraded, and earth-shaking changes have taken place. We can eat and drink every day like the Chinese New Year, but are we really developed?
As early as 1987 , Japan's GDP surpassed the former Soviet Union to become the world's second largest economy, when the domestic market economy was only a few years old? How many years has it been since the farmland was distributed to the household? After 2008 , the GDP between China and Japan began to approach, and after 2010 , China surpassed Japan to become the world's second largest economy. China is indeed developing rapidly, but we cannot compare the current economic development achievements with the long-term downturn of the Japanese economy, so as to blindly and confidently look down on Japan.
The accompanying translators and local tour guides on this trip are all Chinese who have lived in Japan for more than 20 years. Through their introduction and exchange, we will compare what we have seen and heard between China and Japan from time to time, as well as the enterprises of both sides. The accompanying Tian Translator is also a senior management consultant and is often invited to teach for some companies in China. He said, "Japan has a complete social security system, and employees' working hours are stable at 7-8 hours without worrying about education, medical care and housing prices. But every time I go to China to see the working conditions of front-line workers, I feel very sad. " But it is this kind of "sad " that makes more and more Chinese entrepreneurs and executives have a strong and urgent need to change their business management.
Although China's total economic volume has surpassed that of Japan, China's land area is 25 times that of Japan, and its population is more than 10 times that of Japan. Simply put, Japan is the area of Yunnan Province, but I need not say much about Japan's economic influence, and everyone understands it. The advantages of Japan's economy are prominently reflected in three aspects: industrial manufacturing, financial strength and technological advantages, which are the three pillars for Japan to maintain world economic hegemony.
As of 2019 , Japan has a total of 33259 100-year-old enterprises and 8 millennium-old enterprises. Among the world's ,500 companies, Japan has a total of 68 multinational companies on the list, second only to the United States. Toyota, Mitsubishi, Nissan, Sony, Toshiba, Panasonic and other world-renowned companies and brands are all world-renowned for their product technical content and quality excellence. Mr. Tian said that Japanese products rarely have quality problems, let alone fake and shoddy products. Hearing this, I feel a little burnt on my face. Made in Japan seems to be synonymous with brand, technology and quality. What about made in China?
2. attaches importance to the gap in culture and education between the two countries
10 January 9 , Japanese chemist Akira Yoshino won the 2019 Nobel Prize in Chemistry. He is Japan's 27 Nobel Prize winner. The well-known Kyoto University in Japan has produced 15 Nobel Prize winners.
It is said that the Japanese government decided on a scientific plan in 2001 with the slogan "Win 30 Nobel Prize in 50 " . Previously, in the 100-year history of the Nobel Prize, Japan had only 9 winners, but from 2001 to 2019 , Japan had 18 winners. According to the rhythm of one year at a time, "50 years 30 " is almost no suspense.
The frequent Nobel Prize winning of Japanese can let us see the essence through the phenomenon: Japan is not really struggling. The so-called loss of the Japanese economy 118 20 years, in a sense, is definitely the 120 of their scientific and technological innovation 20 years. Whoever has the most advanced technology can dominate the development trend of the industry. The Nobel Prize is a powerful weapon developed by Japan, even a shining blade. During the visit to Dafu Group, I was very shocked by what the narrator said, "The two storage systems we visited last have not yet been put into the market because our customer units still have a lot of manual links, but we are ready to meet the development of the times! " Yes, when we say we must strive to be prepared for the change, our neighbors are ready!
AVEX , we also learned that the company was hit hard by the world financial crisis of 2008 , but there was no layoff as we imagined. Instead, we spent more energy on personnel training and technological innovation. After ten years of sharpening, AVEX production of gearbox spool products occupy the first place in the world, supplied to Toyota, Aisin, BMW and other car companies, as well as many Chinese car companies. Isn't this a retreat?
Japanese yen is a famous Japanese biologist, Ichiya Higuchi on the 140 5000 Japanese yen is a famous Japanese writer, and the person with firm eyes and serious face on the largest denomination 10000 Japanese yen is educator and thinker Yukichi Fukuzawa. There is no general or emperor in the Japanese yen. Through this subtle way, Japan tells the public that scholars must be respected and education must be valued. Only science and education can rejuvenate the country. Japanese university teachers will not worry about being left out or losing their jobs because they have not produced scientific research results for a period of time. In the research process, they are rarely interfered by the government and society, such as assessment and evaluation. Long-term concentration on academic research. Of course, Japan is basically a lifelong career country. Many countries, especially China and the United States, believe that talents can only be valuable if they move, but this statement obviously does not exist in Japan.
The two teachers who did the Toyota TPS
41 years and retired to the second-line training. Director Ishigaki Zhongzheng was originally responsible for the production and management of Land Cruisers in Toyota's own factory, and now Toyota is doing talent training. It is understood that Japanese employees will receive paid pre-job training for 3-12 months before starting their jobs. Toyota's training cycle is 6 months and Mitsubishi's 12 months. These professionally trained employees will be able to adapt to their jobs as soon as they take up their jobs. This established corporate training system in the Japanese workplace is beyond our ability to afford. Although some large state-owned enterprises in China have also begun to do pre-job training, they have not made long-term systematization like Japanese enterprises. Fortunately, Tencent, Ali and Huawei have deeply realized the important task of rejuvenating enterprises and the country through science and education. This year Tencent has awarded 1.5
scientists. It is hoped that more and more young scholars will turn their attention to academic research and devote themselves to scientific research and innovation. This road is very difficult, but someone must go. (To be continued) (Ye Liqing)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31